Daws D. Ryan Insider Trades

Insider Trading History

Track insider trading activity for Daws D. Ryan. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
enGene Holdings
enGene Holdings ENGN
Chief Financial Officer
Holding Value $376k 220,000 shares
Last Trade
Jan 30, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.1M 220,000 shares
$9.53
$1.71
enGene Holdings- Warrants (31/10/2028)
enGene Holdings- Warrants (31/10/2028) ENGNW
Chief Financial Officer
Holding Value $61.6k 220,000 shares
Last Trade
Jan 30, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$605k 220,000 shares
$2.75
$0.28
enGene Holdings- Warrants (31/10/2028)
enGene Holdings- Warrants (31/10/2028) ENGNW
Chief Financial Officer
Holding Value $78.3k 280,000 shares
Last Trade
Jan 29, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$256k 280,000 shares
$0.92
$0.28
enGene Holdings
enGene Holdings ENGN
Chief Financial Officer
Holding Value $479k 280,000 shares
Last Trade
Jan 29, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.07M 280,000 shares
$7.39
$1.71
enGene Holdings- Warrants (31/10/2028)
enGene Holdings- Warrants (31/10/2028) ENGNW
Chief Financial Officer
Holding Value $64.9k 232,000 shares
Last Trade
Nov 30, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$151k 232,000 shares
$0.65
$0.28
enGene Holdings
enGene Holdings ENGN
Chief Financial Officer
Holding Value $397k 232,000 shares
Last Trade
Nov 30, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.78M 232,000 shares
$7.66
$1.71
Concert Pharmaceuticals
Concert Pharmaceuticals CNCE
Chief Financial Officer
Holding Value $691k 82,500 shares
Last Trade
Jan 04, 2017 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$905k 82,500 shares
$10.97
$8.37
Concert Pharmaceuticals
Concert Pharmaceuticals CNCE
Chief Financial Officer
Holding Value $419k 50,000 shares
Last Trade
Jan 07, 2016 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$843k 50,000 shares
$16.85
$8.37
Concert Pharmaceuticals
Concert Pharmaceuticals CNCE
Chief Financial Officer
Holding Value $419k 50,000 shares
Last Trade
Jun 10, 2014 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$420k 50,000 shares
$8.40
$8.37
Concert Pharmaceuticals
Concert Pharmaceuticals CNCE
Chief Financial Officer
Holding Value $1.04M 123,893 shares
Last Trade
Feb 19, 2014 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.75M 123,893 shares
$14.09
$8.37

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up